Idiopathic Inflammatory Myopathy
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of Efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy has comp…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy [Phase 2, Phase 3]
An open-label Phase 2/3 trial to evaluate the safety and efficacy of CABA-201 in active idiopathic inflammatory myopathy and related juvenil…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases [Phase 1]
Phase 1 clinical trial evaluating the safety of CD19-targeted CAR-T cell therapy produced at Gustave Roussy for adults with severe and refra…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders [NA]
A completed clinical trial evaluating the safety and acute effects of a knee-hip powered soft exoskeleton in people with neuromuscular disor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders [NA]
A completed clinical trial assessing safety and acute effects of a lower-limb powered dermoskeleton in patients with neuromuscular disorders…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of BEN301 Injection in the Treatment of Autoimmune Diseases [EARLY_Phase 1]
Early Phase 1 clinical trial update for BEN301 injection evaluating safety in autoimmune diseases including systemic sclerosis, rheumatoid a…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease [Phase 1]
Phase 1 clinical trial update for ALLO-329, an allogeneic CAR T-cell therapy, in adults with autoimmune diseases including systemic lupus er…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of KITE-363 in Participants With Refractory Autoimmune Diseases [Phase 1]
Phase 1 study evaluating KITE-363 in participants with refractory autoimmune diseases, currently enrolling by invitation, including systemic…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
The sponsor reports an ongoing Phase 2/3 trial assessing the safety and efficacy of ULSC in reducing disease severity and aiding steroid tap…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update on an allogeneic CD19/BCMA-targeted CAR-γδT cell therapy assessing safety and preliminary pharmacodynamics in …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties [NA]
This completed clinical trial evaluated muscle function and the effects of repetitive task training in patients with inflammatory myopathies…
-
CLINICAL_TRIALS withdrawal · 2026-03-05Clinical Trial Update: A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating CLBR001 and SWI019 in autoimmune diseases has been withdrawn from further development.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Add-on Intravenous Immunoglobulins in Early Myositis [Phase 2, Phase 3]
A Phase 2/Phase 3 add-on intravenous immunoglobulin study for early inflammatory myopathies (myositis) is active but not currently recruitin…
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]
A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
Early-phase clinical study of a targeted CD19/BCMA CAR-T therapy for autoimmune diseases is recruiting, including systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy [EARLY_Phase 1]
An early-phase 1 clinical trial of IMPT-514 in systemic lupus erythematosus, ANCA-associated vasculitis, and idiopathic inflammatory myopath…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) [Phase 2, Phase 3]
A Phase 2/Phase 3 study of Telitacicept in inflammatory myopathies is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: GC012F Injection in Refractory Idiopathic Inflammatory Myopathy [EARLY_Phase 1]
An early-phase clinical trial update indicates GC012F injection is being evaluated for refractory idiopathic inflammatory myopathy and is cu…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating the safety and efficacy of a targeted BCMA in vivo lentiviral vector injection for recurrent or r…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) [Phase 1]
Phase 1 Breakfree-1 trial evaluating CC-97540, a CD-19-targeted Nex-T CAR T cell therapy, for severe, refractory autoimmune diseases; the st…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases [NA]
This clinical trial is recruiting to evaluate anti-CD19 IL-10/IL-15 CAR-NK cells for refractory/relapsed autoimmune diseases. Conditions inc…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. [Phase 2]
Phase 2 trial evaluating AlloNK, an allogeneic cord blood-derived NK cell therapy, in combination with Rituximab for relapsing B-cell–depend…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease [Phase 1]
A Phase 1 safety and efficacy study of CTX112 in adults with refractory autoimmune diseases, including systemic lupus erythematosus and syst…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: OM336 in Seropositive Autoimmune Diseases [Phase 1]
Phase 1 trial update for OM336 in seropositive autoimmune diseases; the study in Sjögren's syndrome and idiopathic inflammatory myopathy is …